121 related articles for article (PubMed ID: 30433783)
1. Synthesis and Discovery Novel Anti-Cancer Stem Cells Compounds Derived from the Natural Triterpenoic Acids.
Liu X; Li B; Zhang Z; Wei Y; Xu Z; Qin S; Liu N; Zhao R; Peng J; Yang G; Qi M; Liu T; Xie M; Liu S; Gao X; Lu C; Zhu L; Long X; Kang H; Sun T; Zhou H; Wei M; Yang G; Yang C
J Med Chem; 2018 Dec; 61(23):10814-10833. PubMed ID: 30433783
[TBL] [Abstract][Full Text] [Related]
2. Ursolic acid inhibits the proliferation of human ovarian cancer stem-like cells through epithelial-mesenchymal transition.
Zhang J; Wang W; Qian L; Zhang Q; Lai D; Qi C
Oncol Rep; 2015 Nov; 34(5):2375-84. PubMed ID: 26323892
[TBL] [Abstract][Full Text] [Related]
3. A novel Anti-Cancer Stem Cells compound optimized from the natural symplostatin 4 scaffold inhibits Wnt/β-catenin signaling pathway.
Liu S; Gao X; Zhang L; Qin S; Wei M; Liu N; Zhao R; Li B; Meng Y; Lin G; Lu C; Liu X; Xie M; Liu T; Zhou H; Qi M; Yang G; Yang C
Eur J Med Chem; 2018 Aug; 156():21-42. PubMed ID: 30006166
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of celastrol derivatives as anti-ovarian cancer stem cell agents.
Li X; Ding J; Li N; Liu W; Ding F; Zheng H; Ning Y; Wang H; Liu R; Ren S
Eur J Med Chem; 2019 Oct; 179():667-679. PubMed ID: 31279299
[TBL] [Abstract][Full Text] [Related]
5. Incorporation of a Michael acceptor enhances the antitumor activity of triterpenoic acids.
Heller L; Schwarz S; Perl V; Köwitsch A; Siewert B; Csuk R
Eur J Med Chem; 2015 Aug; 101():391-9. PubMed ID: 26177446
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and in vitro evaluation of novel ursolic acid derivatives as potential anticancer agents.
Hua SX; Huang RZ; Ye MY; Pan YM; Yao GY; Zhang Y; Wang HS
Eur J Med Chem; 2015 May; 95():435-52. PubMed ID: 25841199
[TBL] [Abstract][Full Text] [Related]
7. Inhibiting epidermal growth factor receptor signalling potentiates mesenchymal-epithelial transition of breast cancer stem cells and their responsiveness to anticancer drugs.
Manupati K; Dhoke NR; Debnath T; Yeeravalli R; Guguloth K; Saeidpour S; De UC; Debnath S; Das A
FEBS J; 2017 Jun; 284(12):1830-1854. PubMed ID: 28398698
[TBL] [Abstract][Full Text] [Related]
8. Natural Compounds Targeting Cancer Stem Cells: A Promising Resource for Chemotherapy.
Das PK; Zahan T; Abdur Rakib M; Khanam JA; Pillai S; Islam F
Anticancer Agents Med Chem; 2019; 19(15):1796-1808. PubMed ID: 31272363
[TBL] [Abstract][Full Text] [Related]
9. A novel peptidomimetic therapeutic for selective suppression of lung cancer stem cells over non-stem cancer cells.
Shukla SP; Raymond A; Rustagi V; Kedika SR; Tran O; Wang L; Guo B; Udugamasooriya DG
Bioorg Chem; 2021 Nov; 116():105340. PubMed ID: 34530236
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antitumor activity of ring A modified 11-keto-β-boswellic acid derivatives.
Csuk R; Niesen-Barthel A; Schäfer R; Barthel A; Al-Harrasi A
Eur J Med Chem; 2015 Mar; 92():700-11. PubMed ID: 25618017
[TBL] [Abstract][Full Text] [Related]
11. Berberis libanotica Ehrenb extract shows anti-neoplastic effects on prostate cancer stem/progenitor cells.
El-Merahbi R; Liu YN; Eid A; Daoud G; Hosry L; Monzer A; Mouhieddine TH; Hamade A; Najjar F; Abou-Kheir W
PLoS One; 2014; 9(11):e112453. PubMed ID: 25380390
[TBL] [Abstract][Full Text] [Related]
12. Zoledronic acid inhibits the growth of cancer stem cell derived from cervical cancer cell by attenuating their stemness phenotype and inducing apoptosis and cell cycle arrest through the Erk1/2 and Akt pathways.
Wang L; Liu Y; Zhou Y; Wang J; Tu L; Sun Z; Wang X; Luo F
J Exp Clin Cancer Res; 2019 Feb; 38(1):93. PubMed ID: 30791957
[TBL] [Abstract][Full Text] [Related]
13. 2-Ethoxystypandrone, a novel small-molecule STAT3 signaling inhibitor from Polygonum cuspidatum, inhibits cell growth and induces apoptosis of HCC cells and HCC Cancer stem cells.
Li W; Zhang Q; Chen K; Sima Z; Liu J; Yu Q; Liu J
BMC Complement Altern Med; 2019 Feb; 19(1):38. PubMed ID: 30709346
[TBL] [Abstract][Full Text] [Related]
14. Construction and application of a lung cancer stem cell model: antitumor drug screening and molecular mechanism of the inhibitory effects of sanguinarine.
Yang J; Fang Z; Wu J; Yin X; Fang Y; Zhao F; Zhu S; Li Y
Tumour Biol; 2016 Oct; 37(10):13871-13883. PubMed ID: 27485114
[TBL] [Abstract][Full Text] [Related]
15. Optimization, pharmacophore modeling and 3D-QSAR studies of sipholanes as breast cancer migration and proliferation inhibitors.
Foudah AI; Sallam AA; Akl MR; El Sayed KA
Eur J Med Chem; 2014 Feb; 73():310-24. PubMed ID: 24487236
[TBL] [Abstract][Full Text] [Related]
16. Homopiperazine-rhodamine B adducts of triterpenoic acids are strong mitocans.
Wolfram RK; Fischer L; Kluge R; Ströhl D; Al-Harrasi A; Csuk R
Eur J Med Chem; 2018 Jul; 155():869-879. PubMed ID: 29960206
[TBL] [Abstract][Full Text] [Related]
17. Silencing stem cell factor attenuates stemness and inhibits migration of cancer stem cells derived from Lewis lung carcinoma cells.
Wang L; Wang J; Li Z; Liu Y; Jiang M; Li Y; Cao D; Zhao M; Wang F; Luo F
Tumour Biol; 2016 Jun; 37(6):7213-27. PubMed ID: 26666817
[TBL] [Abstract][Full Text] [Related]
18. The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.
Suresh R; Ali S; Ahmad A; Philip PA; Sarkar FH
Adv Exp Med Biol; 2016; 890():57-74. PubMed ID: 26703799
[TBL] [Abstract][Full Text] [Related]
19. Targeting cancer cells with oleanolic and ursolic acid derived hydroxamates.
Wiemann J; Heller L; Csuk R
Bioorg Med Chem Lett; 2016 Feb; 26(3):907-909. PubMed ID: 26750249
[TBL] [Abstract][Full Text] [Related]
20. B591, a novel specific pan-PI3K inhibitor, preferentially targets cancer stem cells.
Zhou H; Yu C; Kong L; Xu X; Yan J; Li Y; An T; Gong L; Gong Y; Zhu H; Zhang H; Yang X; Li Y
Oncogene; 2019 May; 38(18):3371-3386. PubMed ID: 30635656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
